Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase a-induced activity

Molecular and Cellular Biology

Volumn 31, Issue 22, 2011, Pages 4392-4404

  Luz, Simão ^a   Kongsupho, Patthara ^b   Mendes, Ana Isabel ^c   Romeiras, Francisco ^a   Sousa, Marisa ^a,c   Schreiber, Rainer ^b   Matos, Paulo ^c   Jordan, Peter ^c   Mehta, Anil ^d   Amaral, Margarida D ^a,c   Kunzelmann, Karl ^b   Farinha, Carlos M ^a,c  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; MUTANT PROTEIN; PROTEIN KINASE SYK; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MATURATION; MOUSE; MUTATION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; WILD TYPE; XENOPUS;

ANIMALS; CASEIN KINASE II; CRICETINAE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ION CHANNELS; MICE; MICE, INBRED C57BL; MUTATION; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; XENOPUS LAEVIS;

EID: 83255187903     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05517-11     Document Type: Article

References (42)

1. Barro-Soria, R., R. Schreiber, and K. Kunzelmann. 2008. Bestrophin 1 and 2 are components of the Ca(2) activated Cl(+) conductance in mouse airways. Biochim. Biophys. Acta 1783:1993-2000.
2. Blom, N., T. Sicheritz-Ponten, R. Gupta, S. Gammeltoft, and S. Brunak. 2004. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4:1633-1649.
3. Briel, M., R. Greger, and K. Kunzelmann. 1998. Cl- transport by cystic fibrosis transmembrane conductance regulator (CFTR) contributes to the inhibition of epithelial Na+ channels (ENaCs) in Xenopus oocytes coexpressing CFTR and ENaC. J. Physiol. (Lond.) 508:825-836.
4. Chang, X. B., et al. 1993. Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J. Biol. Chem. 268:11304-11311.
5. Collins, F. S. 1992. Cystic fibrosis: molecular biology and therapeutic implications. Science 256:774-779.
6. Cozza, G., et al. 2009. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. Biochem. J. 421:387-395.
7. Csanady, L., K. W. Chan, A. C. Nairn, and D. C. Gadsby. 2005. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain. J. Gen. Physiol. 125:43-55.
8. Faria, D., et al. 2011. Effect of Annexin A5 on CFTR: regulated traffic or scaffolding? Mol. Membr. Biol. 28:14-29.
9. Farinha, C. M., and M. D. Amaral. 2005. Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol. Cell. Biol. 25:5242-5252.
10. Farinha, C. M., P. Nogueira, F. Mendes, D. Penque, and M. D. Amaral. 2002. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochem. J. 366:797-806.
11. Gentzsch, M., et al. 2004. Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15:2684-2696.
12. Gil, C., et al. 2011. Protein kinase CK2 associates to lipid rafts and its pharmacological inhibition enhances neurotransmitter release. FEBS Lett. 585:414-420.
13. Greenberg, S. 1999. Modular components of phagocytosis. J. Leukoc. Biol. 66:712-717.
14. Guggino, W. B., and B. A. Stanton. 2006. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat. Rev. Mol. Cell Biol. 7:426-436.
15. Jensen, T. J., et al. 1995. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83:129-135.
16. Kanelis, V., R. P. Hudson, P. H. Thibodeau, P. J. Thomas, and J. D. Forman-Kay. 2010. NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J. 29:263-277.
17. Lu, Y., et al. 1998. Co- and posttranslational translocation mechanisms direct cystic fibrosis transmembrane conductance regulator N terminus transmembrane assembly. J. Biol. Chem. 273:568-576.
18. Meacham, G. C., et al. 1999. The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18:1492-1505.
19. Meggio, F., and L. A. Pinna. 2003. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17:349-368.
20. Mehta, A. 2007. The cystic fibrosis transmembrane recruiter the alter ego of CFTR as a multi-kinase anchor. Pflugers Arch. Eur. J. Physiol. 455:215-221.
21. Mendes, A. I., et al. 2011. Antagonistic regulation of cystic fibrosis transmembrane conductance regulator cell surface expression by protein kinases WNK4 and spleen tyrosine kinase. Mol. Cell. Biol. 31:4076-4086.
22. Mense, M., et al. 2006. In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J. 25:4728-4739.
23. Mocsai, A., J. Ruland, and V. L. Tybulewicz. 2010. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat. Rev. Immunol. 10:387-402.
24. Navara, C. S. 2004. The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy. Curr. Pharm. Des. 10:1739-1744.
25. Ostedgaard, L. S., C. Randak, D. Vermeer, P. Karp, and M. J. Welsh. 2006. CK2 phosphorylation influences transepithelial Cl- current in airway epithelia. Pediatr. Pulmonol. 43:224.
26. Pagano, M. A., et al. 2008. Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis. Biochemistry 47:7925-7936.
27. Pagano, M. A., et al. 2010. Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2. Biochem. J. 426:19-29.
28. Peters, K. W., J. Qi, J. P. Johnson, S. C. Watkins, and R. A. Frizzell. 2001. Role of snare proteins in CFTR and ENaC trafficking. Pflugers Arch. 443(Suppl. 1):S65-S69.
29. Pissarra, L. S., et al. 2008. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem. Biol. 15:62-69.
30. Riccaboni, M., I. Bianchi, and P. Petrillo. 2010. Spleen tyrosine kinases: biology, therapeutic targets and drugs. Drug Discov. Today 15:517-530.
31. Riordan, J. R., et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073. (Erratum, 245:1437.)
32. Roxo-Rosa, M., et al. 2006. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms. Proc. Natl. Acad. Sci. U. S. A. 103:17891-17896.
33. Sanderson, M. P., C. W. Lau, A. Schnapp, and C. W. Chow. 2009. Syk: a novel target for treatment of inflammation in lung disease. Inflamm. Allergy Drug Targets 8:87-95.
34. Sarker, R., et al. 2008. Casein kinase 2 binds to the C terminus of Na /H exchanger 3 (NHE3) and stimulates NHE3 basal activity by phosphorylating a separate site in NHE3. Mol. Biol. Cell 19:3859-3870.
35. Schultz, B. D., A. K. Singh, D. C. Devor, and R. J. Bridges. 1999. Pharmacology of CFTR chloride channel activity. Physiol. Rev. 79:S109-S144.
36. Scott-Ward, T. S., and M. D. Amaral. 2009. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone. FEBS J. 276:7097-7109.
37. Tabcharani, J. A., X. B. Chang, J. R. Riordan, and J. W. Hanrahan. 1991. Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature 352:628-631.
38. Takahashi, A., S. C. Watkins, M. Howard, and R. A. Frizzell. 1996. CFTRdependent membrane insertion is linked to stimulation of the CFTR chloride conductance. Am. J. Physiol. 271:C1887-C1894.
39. Treharne, K. J., et al. 2009. Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR. Cell. Physiol. Biochem. 24:347-360.
40. Ulanova, M., et al. 2005. Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L497-L507.
41. Weber, W. M., et al. 2001. Functional integrity of the vesicle transporting machinery is required for complete activation of cFTR expressed in Xenopus laevis oocytes. Pflugers Arch. 441:850-859.
42. Winter, M. C., and M. J. Welsh. 1997. Stimulation of CFTR activity by its phosphorylated R domain. Nature 389:294-296.